Bioline RX Ltd Sponsored ADR (YP2) Cash flow

1 Followers

Bioline RX Ltd Sponsored ADR Cash Flow

DE:YP2's free cash flow for Q2 2026 was $-3.26M. For the 2026 fiscal year, DE:YP2's free cash flow was decreased by $35.76M and operating cash flow was $-3.26M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -8.14M	$ -43.87M	$ -22.61M	$ -26.24M	$ -23.57M
Investing Cash Flow	$ -8.61M	$ 29.37M	$ 1.44M	$ 4.01M	$ -38.22M
Financing Cash Flow	$ 8.95M	$ 20.66M	$ 15.06M	$ 20.44M	$ 57.75M
End Cash Position	$ 3.25M	$ 10.44M	$ 4.25M	$ 10.59M	$ 12.99M
Free Cash Flow	$ -8.16M	$ -43.93M	$ -22.91M	$ -26.56M	$ -23.67M

Currency in USD